Effect of Rectal Ozone ($ O_{3} $) in Severe COVID-19 Pneumonia: Preliminary Results
Abstract The aim of this study is to evaluate the effectiveness of rectal ozone ($ O_{3} $) in COVID-19 patients with severe pneumonia admitted at Hospital Universitario Santa Cristina, Madrid. In a before-and-after study, four patients admitted with severe bilateral pneumonia due to COVID-19 were treated with rectal ozone and confirmed with (+) RT-PCR for SARS-CoV-2 and evaluated afterwards. The analyzed outcome variables were as follows: (a) clinical improvement ($ O_{2} $ saturation and $ O_{2} $ supply); (b) biochemical improvement (fibrinogen, D-dimer, urea, ferritin, LDH, IL-6, and CRP); (c) radiological improvement. The treatment protocol consisted of 5 sessions (1 session/day) of intra-rectal ozone, applied in a volume of 100 mL and a concentration of 35 μg/mL. The Protocol was previously approved by the Hospital’s Health Care Ethics Committee (CEAS) (Report 15/4/2020) for compassionate use in the face of this exceptional pandemic situation, and prior informed consent was obtained from the patient/legal representative. The patients improved oxygen saturation, as observed by the lower number of desaturations and the lower supply of $ O_{2} $. Biomarkers of inflammation decreased (fibrinogen, D-dimer, urea, ferritin, LDH, IL-6, and CRP). Finally, the radiological signs of bilateral viral pneumonitis improved between 1 and 2 grades based on Taylor’s radiological scale. Rectal ozone decreases $ O_{2} $ supply and improves $ O_{2} $ saturation, decreases inflammation biomarkers, and improves Taylor’s radiological grade in patients with severe COVID-19 pneumonia. Rectal ozone is a safe, effective, cheap, and simple alternative capable of acting on the SARS-CoV-2 virus, and it is presented as an adjunctive therapeutic option to consider in the management of severe bilateral COVID-19 pneumonia..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
SN comprehensive clinical medicine - 2(2020), 9 vom: 03. Aug., Seite 1328-1336 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fernández-Cuadros, Marcos Edgar [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| doi: |
10.1007/s42399-020-00374-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR040966062 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR040966062 | ||
| 003 | DE-627 | ||
| 005 | 20230519224655.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s42399-020-00374-1 |2 doi | |
| 035 | |a (DE-627)SPR040966062 | ||
| 035 | |a (SPR)s42399-020-00374-1-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Fernández-Cuadros, Marcos Edgar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of Rectal Ozone ($ O_{3} $) in Severe COVID-19 Pneumonia: Preliminary Results |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract The aim of this study is to evaluate the effectiveness of rectal ozone ($ O_{3} $) in COVID-19 patients with severe pneumonia admitted at Hospital Universitario Santa Cristina, Madrid. In a before-and-after study, four patients admitted with severe bilateral pneumonia due to COVID-19 were treated with rectal ozone and confirmed with (+) RT-PCR for SARS-CoV-2 and evaluated afterwards. The analyzed outcome variables were as follows: (a) clinical improvement ($ O_{2} $ saturation and $ O_{2} $ supply); (b) biochemical improvement (fibrinogen, D-dimer, urea, ferritin, LDH, IL-6, and CRP); (c) radiological improvement. The treatment protocol consisted of 5 sessions (1 session/day) of intra-rectal ozone, applied in a volume of 100 mL and a concentration of 35 μg/mL. The Protocol was previously approved by the Hospital’s Health Care Ethics Committee (CEAS) (Report 15/4/2020) for compassionate use in the face of this exceptional pandemic situation, and prior informed consent was obtained from the patient/legal representative. The patients improved oxygen saturation, as observed by the lower number of desaturations and the lower supply of $ O_{2} $. Biomarkers of inflammation decreased (fibrinogen, D-dimer, urea, ferritin, LDH, IL-6, and CRP). Finally, the radiological signs of bilateral viral pneumonitis improved between 1 and 2 grades based on Taylor’s radiological scale. Rectal ozone decreases $ O_{2} $ supply and improves $ O_{2} $ saturation, decreases inflammation biomarkers, and improves Taylor’s radiological grade in patients with severe COVID-19 pneumonia. Rectal ozone is a safe, effective, cheap, and simple alternative capable of acting on the SARS-CoV-2 virus, and it is presented as an adjunctive therapeutic option to consider in the management of severe bilateral COVID-19 pneumonia. | ||
| 650 | 4 | |a Ozone |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Ozone therapy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pneumonia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a COVID-19 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a SARS-CoV-2 |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Albaladejo-Florín, María Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Álava-Rabasa, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Usandizaga-Elio, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Martinez-Quintanilla Jimenez, Dolores |e verfasserin |4 aut | |
| 700 | 1 | |a Peña-Lora, Daiana |e verfasserin |4 aut | |
| 700 | 1 | |a Neira-Borrajo, Inmaculada |e verfasserin |4 aut | |
| 700 | 1 | |a López-Muñoz, María Jesús |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-de-Cía, Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Moro, Olga Susana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d [Cham] : Springer International Publishing, 2019 |g 2(2020), 9 vom: 03. Aug., Seite 1328-1336 |w (DE-627)SPR038535785 |w (DE-600)2947252-0 |x 2523-8973 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2020 |g number:9 |g day:03 |g month:08 |g pages:1328-1336 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s42399-020-00374-1 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2020 |e 9 |b 03 |c 08 |h 1328-1336 | ||